on 22 Aug 2023
Last Applicant/ Owned by
Koto-ku,
Tokyo 136-0075
JP
Serial Number
79342589 filed on 25th Feb 2022
Registration Number
7141339 registered on 22nd Aug 2023
Correspondent Address
M. Scott Alprin Alprin Law Offices, P.C.
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials Read More
Granting of licenses to others for the use of intellectual property; legal services, namely, exploitation of industrial property rights
11th 000101
11th 000101
Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals for others; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive substances
11th 000101
11th 000101
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis of cancer; chemical reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes for the treatment of cancer; synthetic peptides for pharmaceutical purposes for the diagnosis of cancer; pharmaceuticals consisting of antibodies for the treatment of cancer; pharmaceuticals consisting of antibodies for the diagnosis of cancer; pharmaceuticals consisting of antibody fragments for the treatment of cancer; pharmaceuticals consisting of antibody fragments for the diagnosis of cancer; pharmaceuticals consisting of antibody derivatives for the treatment of cancer; pharmaceuticals consisting of antibody derivatives for the diagnosis of cancer; antibodies for medical purposes
11th 000101
11th 000101
Industrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents
11th 000101
11th 000101
Custom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction of pharmaceuticals and veterinary preparations; custom synthesis and refining of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom synthesis and refining of pharmaceuticals consisting of antibodies; custom manufacture of pharmaceuticals consisting of antibodies; custom synthesis and refining of pharmaceuticals consisting of antibody fragments; custom manufacture of pharmaceuticals consisting of antibody fragments; custom synthesis and refining of pharmaceuticals consisting of antibody derivatives; custom manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies; custom radioactive labeling of antibody fragments; custom radioactive labeling of antibody derivatives; custom radioactive labeling of peptides
11th 000101
11th 000101
No 79342589
No Service Mark
No 0332004
No
No
No
No
Yes
Yes
No
No
The mark consists of the Greek letter "alpha" before the term "STARTZ" appearing as one word in stylized format.
| Status Date | Action Taken |
|---|---|
| 10th May 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 10th May 2024 | CORRECTION UNDER SECTION 7 - PROCESSED |
| 09th May 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 19th Dec 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 27th Nov 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| 27th Nov 2023 | FINAL DISPOSITION PROCESSED |
| 22nd Nov 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 28th Aug 2023 | TEAS SECTION 7 REQUEST RECEIVED |
| 22nd Aug 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 22nd Aug 2023 | REGISTERED-PRINCIPAL REGISTER |
